227 related articles for article (PubMed ID: 28093541)
21. Role of ApoB-516C/T promoter gene polymorphism in the risk of Hepatitis C virus infection in Egyptian patients and in gender susceptibility.
Khalifa RH; Labib DA; Kamel MA; Shahin RMH; Bahgat DMR; Riad NM; El Khateeb E; El-Deeb AM; Hassan M
J Med Virol; 2017 Sep; 89(9):1584-1589. PubMed ID: 28370191
[TBL] [Abstract][Full Text] [Related]
22. Association of Toll-like receptor (TLR) 2, 3 and 9 genes polymorphism with prostate cancer risk in North Indian population.
Mandal RK; George GP; Mittal RD
Mol Biol Rep; 2012 Jul; 39(7):7263-9. PubMed ID: 22311043
[TBL] [Abstract][Full Text] [Related]
23. Rapidity of fibrosis progression in liver transplant recipients with recurrent hepatitis C is influenced by toll-like receptor 3 polymorphism.
Citores MJ; Pérez-Pulgar S; Duca A; Crespo G; de la Fuente S; Vilches C; Navasa M; Cuervas-Mons V
Clin Transplant; 2016 Jul; 30(7):810-8. PubMed ID: 27101936
[TBL] [Abstract][Full Text] [Related]
24. Involvement of Toll-like receptors in cervical cancer susceptibility among Tunisian women.
Zidi S; Verdi H; Yilmaz-Yalcin Y; Yazici AC; Gazouani E; Mezlini A; Atac FB; Yacoubi-Loueslati B
Bull Cancer; 2014 Oct; 101(10):E31-5. PubMed ID: 25373689
[TBL] [Abstract][Full Text] [Related]
25. Toll-like receptors genes polymorphisms and the occurrence of HCMV infection among pregnant women.
Wujcicka W; Paradowska E; Studzińska M; Wilczyński J; Nowakowska D
Virol J; 2017 Mar; 14(1):64. PubMed ID: 28340580
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor-α -G308A polymorphism is associated with liver pathological changes in hepatitis C virus patients.
Bader El Din NG; Farouk S; El-Shenawy R; Ibrahim MK; Dawood RM; Elhady MM; Salem AM; Zayed N; Khairy A; El Awady MK
World J Gastroenterol; 2016 Sep; 22(34):7767-77. PubMed ID: 27678360
[TBL] [Abstract][Full Text] [Related]
27. The association of toll-like receptor 4 polymorphism with hepatitis C virus infection in Saudi Arabian patients.
Al-Qahtani AA; Al-Anazi MR; Al-Zoghaibi F; Abdo AA; Sanai FM; Khan MQ; Albenmousa A; Al-Ashgar HI; Al-Ahdal MN
Biomed Res Int; 2014; 2014():357062. PubMed ID: 25177689
[TBL] [Abstract][Full Text] [Related]
28. Single-nucleotide polymorphisms in genes encoding toll-like receptor -2, -3, -4, and -9 in case-control study with breast cancer.
Etokebe GE; Knezević J; Petricević B; Pavelić J; Vrbanec D; Dembić Z
Genet Test Mol Biomarkers; 2009 Dec; 13(6):729-34. PubMed ID: 19810822
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of neonatal Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in HBV intrauterine transmission susceptibility.
Gao Y; Guo J; Zhang F; Guo Z; Zhang LR; Wang T; Wang B; Feng SY; Wang SP
Epidemiol Infect; 2015 Jul; 143(9):1868-75. PubMed ID: 25388852
[TBL] [Abstract][Full Text] [Related]
30. Association of BAFF -871C/T Promoter Polymorphism with Hepatitis C-Related Mixed Cryoglobulinemia in a Cohort of Egyptian Patients.
Ayad MW; Elbanna AA; Elneily DA; Sakr AS
Mol Diagn Ther; 2015 Apr; 19(2):99-106. PubMed ID: 25800158
[TBL] [Abstract][Full Text] [Related]
31. Analysis of Toll-like Receptor 9 Gene Polymorphisms in Sepsis.
Atalan N; Karagedik H; Acar L; Isbir S; Yilmaz SG; Ergen A; Isbir T
In Vivo; 2016 09-10; 30(5):639-43. PubMed ID: 27566084
[TBL] [Abstract][Full Text] [Related]
32. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
Motawi TK; Shaker OG; Ismail MF; Sayed NH
Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
[TBL] [Abstract][Full Text] [Related]
33. Promoter region polymorphism & expression profile of toll like receptor-3 (TLR-3) gene in chronic hepatitis C virus (HCV) patients from India.
Medhi S; Deka M; Deka P; Swargiary SS; Hazam RK; Sharma MP; Gumma PK; Asim M; Kar P
Indian J Med Res; 2011 Aug; 134(2):200-7. PubMed ID: 21911973
[TBL] [Abstract][Full Text] [Related]
34. Toll-like receptor 2 and 9 genetic polymorphisms and the susceptibility to B cell Non-Hodgkin Lymphoma in Egypt.
Rahman HA; Khorshied MM; Khorshid OM; Mahgoub SM
Ann Hematol; 2014 Nov; 93(11):1859-65. PubMed ID: 24912772
[TBL] [Abstract][Full Text] [Related]
35. TLR3 Gene Polymorphism in HCV Infection in the Kazakh Population of Western Kazakhstan.
Nurlanova G; Zhumagaliyeva G; Iskakova A; Astrakhanov A; Kurmangazin M
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3925-3930. PubMed ID: 38019252
[TBL] [Abstract][Full Text] [Related]
36. Single-nucleotide polymorphism of Toll-like receptor 4 and interleukin-10 in response to interferon-based therapy in Egyptian chronic hepatitis C patients.
Sadik NA; Shaker OG; Ghanem HZ; Hassan HA; Abdel-Hamid AH
Arch Virol; 2015 Sep; 160(9):2181-95. PubMed ID: 26095186
[TBL] [Abstract][Full Text] [Related]
37. Role of the functional Toll-Like receptor-9 promoter polymorphism (-1237T/C) in increased risk of end-stage renal disease: a case-control study.
Yang HY; Lu KC; Lee HS; Huang SM; Lin YF; Wu CC; Salter DM; Su SL
PLoS One; 2013; 8(3):e58444. PubMed ID: 23472199
[TBL] [Abstract][Full Text] [Related]
38. Association of Toll-Like Receptor 3 Single-Nucleotide Polymorphisms and Hepatitis C Virus Infection.
Al-Anazi MR; Matou-Nasri S; Abdo AA; Sanai FM; Alkahtani S; Alarifi S; Alkahtane AA; Al-Yahya H; Ali D; Alessia MS; Alshahrani B; Al-Ahdal MN; Al-Qahtani AA
J Immunol Res; 2017; 2017():1590653. PubMed ID: 28127569
[TBL] [Abstract][Full Text] [Related]
39. Endosomal toll-like receptor gene polymorphisms and susceptibility to HIV and HCV co-infection - Differential influence in individuals with distinct ethnic background.
Valverde-Villegas JM; Dos Santos BP; de Medeiros RM; Mattevi VS; Lazzaretti RK; Sprinz E; Kuhmmer R; Chies JA
Hum Immunol; 2017 Feb; 78(2):221-226. PubMed ID: 28062211
[TBL] [Abstract][Full Text] [Related]
40. Toll-like receptor 8 (TLR8) polymorphisms are associated with non-progression of chronic hepatitis C in HIV/HCV coinfected patients.
Fernández-Rodríguez A; Berenguer J; Jiménez-Sousa MA; García-Álvarez M; Aldámiz-Echevarría T; Pineda-Tenor D; Diez C; de la Barrera J; Bellon JM; Briz V; Resino S
Infect Genet Evol; 2015 Dec; 36():339-344. PubMed ID: 26455634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]